Philip Ozuah, MD

The House Ways and Means Committee (Reps. Jason Smith, R-Mo., and David Schweikert, R-Ariz.) sent letters directly to Dr. Ozuah demanding documents related to allegations that Montefiore Medical Center transplanted organs procured from American donors into wealthy foreign recipients who traveled to the U.S. specifically to receive transplants.

Over 100,000 Americans remain on organ transplant waiting lists; thousands die waiting each year.

Lawmakers explicitly questioned whether this practice violates Montefiore's community benefit obligations under its tax-exempt status.

Subpoena threats were issued if Montefiore failed to comply by February 10, 2026.

Significance: This is not a routine regulatory inquiry — it is a targeted congressional investigation with potential to challenge Montefiore's 501(c)(3) status.

House Ways and Means oversight subcommittee hearing focused on tax-exempt hospitals' community spending, executive compensation, and "anticompetitive" behavior through provider consolidation.

Montefiore was specifically cited as an example of the pattern under investigation.

Calls were made for more stringent reporting requirements for nonprofit hospital community benefit spending.

Nurses, medical residents, and union leaders have publicly accused Montefiore of operating a "two-tier health system" — investing heavily in suburban Westchester facilities (e.g., $750M White Plains hospital) while allowing Bronx facilities to deteriorate.

White Plains patients get private rooms and capital investment; Bronx patients "languish in emergency rooms for days at a time" on hallway stretchers.

Management proposed a "restructuring" plan for the Bronx that would reduce bed counts and transfer patients to suburban hospitals — effectively redirecting the safety-net population away from their community.

Nearly 15,000 NYSNA members from Montefiore, New York-Presbyterian, and Mount Sinai walked off the job.

Montefiore nurses accused management of "corporate greed" and systematic "Bronx disinvestment."

Core grievances: unsafe staffing ratios, overcrowded emergency departments, patients on hallway stretchers, and a management team earning tens of millions while frontline workers demanded basic resource adequacy.

Montefiore medical residents publicly protested understaffing and long hours, describing themselves as "exploited."

Residents reported routinely working 80-hour weeks, treating patients in hallways, and being among the lowest-paid medical residents in the Bronx.

A first-year resident directly accused Montefiore leadership of "pursuing profits over patients."

Montefiore planned to relocate a Fordham Road clinic serving a largely immigrant and poor neighborhood 2.5 miles south — on the advice of McKinsey & Company — to save on real estate costs.

No community input was sought. The New York State Academy of Family Physicians wrote directly to Dr. Ozuah urging reconsideration.

The move would have disrupted care access for one of the most vulnerable patient populations in the system.

Cleaning staff filed a class-action lawsuit alleging systematic denial of overtime pay, seeking to cover 200+ workers.

Workers reported accumulating up to 80 hours per week without receiving legally mandated time-and-a-half overtime compensation.

The U.S. Department of Labor / OSHA cited Montefiore Medical Center for workplace safety violations (January 2022).

Ozuah collected a $9M early retirement payout in 2018 while simultaneously transitioning to a higher role (CEO of the umbrella entity). He never retired. This has the hallmarks of a deferred compensation acceleration event disguised as a retirement benefit — a mechanism that triggered a large lump-sum payout without any actual separation from employment.

Montefiore participates in the 340B Drug Pricing Program but there is no public evidence it passes drug discount savings to its overwhelmingly low-income patient population. If Montefiore is pocketing the 340B spread while its patients — 75–85% on Medicaid/Medicare — pay full price, this represents a direct betrayal of the program's intent.